This session will emphasize the critical importance of embedding Diversity, Equity, and Inclusion (DEI) initiatives directly into clinical trial budgets to foster more inclusive and representative research. Attendees will gain insight into how funding efforts—such as community outreach, culturally relevant recruitment strategies, and equitable participant compensation—can drive equity and efficiency in clinical trials. The discussion will highlight the risks of excluding DEI initiatives, such as recruitment delays, underrepresentation, and missed opportunities to reach underserved populations. Participants will leave equipped with practical strategies and advocacy tools to secure DEI-focused budget allocations during trial planning and negotiations, ensuring sustainable engagement and equitable access to clinical trials.
• Denise Quint - Independent Contractor - Denise Quint, LLC
• LaTisha Weaver - CEO & Founder - LDM Clinical Research Source